If you think that management and the Board was so convinced about the product validIty that they approved and spent +$10 millions in Inventory, you could ask yourself if we deal with dummies or worst.
It is just amazing how dreadfully this company has been able to stay alive on the promise of the "Holy Grail solution" for so many illnesses.
Vitrogro + Inventory for Wounds In the EU
VLU solution
DFU solution ready in the pipeline
Ocular for eye wounds in an orphan stage
The enigmatic VF000X super protein
Come on. Are we so idiots?
- Forums
- ASX - By Stock
- DLM
- Ann: Results of Phase 2 Clinical Trial
Ann: Results of Phase 2 Clinical Trial, page-128
-
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online